Who is sponsoring NCT03594253?

NCT03594253 is sponsored by Yeshiva University.

What drugs are being tested in NCT03594253?

Interventions in NCT03594253: Regulation Focused Psychotherapy for Children.

What condition does NCT03594253 study?

NCT03594253 studies Oppositional Defiant Disorder, Oppositional Defiant Disorder in Children.

Is NCT03594253 still recruiting?

NCT03594253 is currently completed. Last updated 30 January 2023.

Last reviewed 2023-01-30 · How we verify

NCT03594253: RFP-C

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Regulation Focused Psychotherapy for Children

Completed NA Last updated 30 January 2023

What this trial tests

NA trial testing Regulation Focused Psychotherapy for Children in Oppositional Defiant Disorder in 40 participants. Completed in 30 June 2020.

Timeline

1 January 2017

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Yeshiva University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 January 2017
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	1 location across United States

Drugs / interventions tested

Regulation Focused Psychotherapy for Children

Conditions studied

Oppositional Defiant Disorder — all drugs for Oppositional Defiant Disorder →
Oppositional Defiant Disorder in Children — all drugs for Oppositional Defiant Disorder in Children →

Sponsor

Yeshiva University

Who can join

Adults 5 to 12, any sex, with Oppositional Defiant Disorder or Oppositional Defiant Disorder in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this project is to conduct a study of RFP-C for children with disruptive behaviors. Regulation Focused Psychotherapy for Children (RFP-C) is a twice a week, play therapy intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Randomized controlled trial of Regulation Focused Psychotherapy for children: A manualized psychodynamic treatment for externalizing behaviors.
Prout TA, Rice T, Chung H, Gorokhovsky Y, et al · · 2022 · cited 11× · PMID 34583626 · DOI 10.1080/10503307.2021.1980626
Defense-Oriented Psychoanalytic Psychotherapy as a Tailored Treatment for Boys: Neurobiological Underpinnings to Male-Specific Response Tested in Regulation-Focused Psychotherapy for Children.
Rice T, Prout TA, Walther A, Hoffman L. · · 2022 · cited 3× · PMID 35892348 · DOI 10.3390/bs12080248

Verify or expand the search:

Other recruiting trials for Oppositional Defiant Disorder

Currently open trials in the same condition.

NCT06902649 — Step-by-Step: Evaluation of a Stepped Care Model · NA · recruiting
NCT06831123 — Pathways 2 Success · Phase 1, PHASE2 · recruiting
NCT06410495 — Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot) · NA · recruiting
NCT06350292 — SLEEP-COPE: Sleep Intervention for Oppositional Children · NA · recruiting
NCT07456631 — ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence · NA · recruiting

Other Yeshiva University trials

Trials by the same sponsor.

NCT07212673 — Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder · NA · recruiting
NCT06604299 — Digital Mindfulness Meditation-enhanced Cognitive Behavioral Therapy (CBT-MM) for Binge Eating Disorder · NA · completed
NCT06150612 — Unwinding Anxiety for Migraine: Pilot · NA · unknown
NCT05753410 — App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa · NA · completed
NCT06781840 — Promoting Health Through Play Program: Improving Parent and Child Outcomes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03594253 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yeshiva University
Last refreshed: 30 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03594253.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing